Results 221 to 230 of about 84,496 (265)
Some of the next articles are maybe not open access.
Status of Platelet Collection and Platelet Transfusion
Therapeutic Apheresis, 2001Abstract: Platelet product derived from single donor plateletpheresis is required to reduce the risks of adverse reactions by blood transfusion. The objectives of this study are to evaluate the status of platelet collection and its efficacy by various kinds of plateletpheresis equipment and to assess the achievement of platelet transfusion by platelet ...
S, Omokawa +9 more
openaire +2 more sources
Platelet dose for prophylactic platelet transfusions
Expert Review of Hematology, 2010Although guidelines exist to deal with some aspects of platelet transfusion practice, many important clinical issues have not been addressed in large randomized controlled trials (RCTs). Slichter et al. conducted a RCT of prophylactic platelet transfusions to determine the effects of the dose of platelets on clinical signs of bleeding, the use of ...
Joan, Cid, Miguel, Lozano
openaire +2 more sources
Guidelines for Platelet Transfusion
JAMA: The Journal of the American Medical Association, 1988Thirty years ago platelet transfusions were not available. Thrombocytopenic bleeding led to morbidity and mortality in patients with aplastic anemia and hematologic malignancies. Now, platelet transfusions generally are as available as any physician wishes. This ready availability and the development of potent antibiotics have allowed hematologists and
openaire +2 more sources
Medical Clinics of North America, 1977
Platelet transfusions are of unquestionably proven benefit for the correction of thrombocytopenia or functional platelet disorders, and they have allowed for more intensive antineoplastic therapy. With the advent of blood component therapy most modern blood banks now have the capabilities for supplying at least limited quantities of platelets ...
openaire +2 more sources
Platelet transfusions are of unquestionably proven benefit for the correction of thrombocytopenia or functional platelet disorders, and they have allowed for more intensive antineoplastic therapy. With the advent of blood component therapy most modern blood banks now have the capabilities for supplying at least limited quantities of platelets ...
openaire +2 more sources
Refractoriness to platelet transfusion
Current Opinion in Hematology, 2002This review discusses the causes of refractoriness to platelet transfusions and presents three options for its management. Platelet refractoriness is a complication of platelet transfusion that affects variable proportions of patients, mostly depending on their diagnosis, previous immunologic stimuli, and type of blood products used for transfusion.
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1965
The safety and hemostatic effects of platelet transfusions have been well demonstrated in a National Cancer Institute—Acute Leukemia Task Force supported collaborative study among five major institutions and the National Laboratories of the American Red Cross.
openaire +2 more sources
The safety and hemostatic effects of platelet transfusions have been well demonstrated in a National Cancer Institute—Acute Leukemia Task Force supported collaborative study among five major institutions and the National Laboratories of the American Red Cross.
openaire +2 more sources
Platelets—to transfuse or not to transfuse
The Lancet, 2012Neil, Blumberg +3 more
openaire +2 more sources
CRC Critical Reviews in Clinical Laboratory Sciences, 1970
S A, Johnson, J W, Rebuck
openaire +2 more sources
S A, Johnson, J W, Rebuck
openaire +2 more sources